Also part of the UPMC family:

Outcomes with Innovative Protocols

Treatment Outcomes with Innovative Protocols

Researchers at the McGowan Institute are involved in all stages of finding and designing new therapies. We take what we learn at the lab bench and deliver innovative treatments to the patient's bedside.

Before a new treatment is ready for patients in doctors' offices and hospitals, it goes through a long development and testing process. It can take years or even decades for scientific, hospital, and government regulators to approve.

New Treatments: The Path from “Bench to Bedside”

Work on a new treatment often starts small in test tubes and Petri dishes at the lab bench. As researchers gather evidence and refine techniques, they translate their work to larger and larger scales.

Once a new therapy has proven safe and effective in preclinical studies, small-scale testing in human volunteers can begin. If these first tests — called clinical trials — are promising, we can expand them to include larger and larger numbers of people.

Once large-scale trials prove a new treatment safely works, we can offer it into clinical practice.

At the McGowan Institute, we perform the most rigorous research to help speed up this long, but necessary, testing and approval process. We also work hard to prove our treatments to companies that can produce and market them so they can help patients sooner.

Therapies developed by McGowan Institute researchers are either in clinical trials or in use today.

Meet Patients of the McGowan Institute

Read how we've helped others through our innovative research and treatments: